Articles published in Brain Disorders & Therapy have been cited by esteemed scholars and scientists all around the world. Brain Disorders & Therapy has got h-index 12, which means every article in Brain Disorders & Therapy has got 12 average citations.
Following are the list of articles that have cited the articles published in Brain Disorders & Therapy.
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Year wise published articles |
46 | 13 | 13 | 11 | 16 |
Year wise citations received |
103 | 84 | 90 | 74 | 83 |
Journal total citations count | 713 |
Journal h-index | 12 |
Perera N, Javeed M, Lyketsos CG, Leroi I. Neuropsychiatric aspects of dementia. InDementia 2017:79-86.
Khadijah B. Research & Reviews: Journal of Medical and Health Sciences.
Kiran Mayee K. Emerging Trends in Neuropsychiatry.
Zasler ND, Aloisi M, Contrada M, Formisano R. Disorders of consciousness terminology: history, evolution and future directions. Brain injury. 20;9:1-6.
赵文波. è„Šé«“æŸä¼¤åŽè„‘脊液在内æºæ€§ç¥žç»å¹²ç»†èƒžå¢žæ®–分化ä¸ä½œç”¨çš„å®žéªŒç ”ç©¶è¿›å±•. 贵州医è¯. 2016 Nov 11(2016 å¹´ 09):992-4.
Danielski LG. Avaliação da neuroproteção da vitamina B6 na sepse experimental. Programa de Pós-Graduação em Ciência da Saúde. 2016.
Грабчак ОІ. Метаболізм рибофлавіну до його коферментних форм в тканинах щурів різного віку.
Huang H. Mass Spectrometry-Based Metabolomics: Platform Development and Application to Neurodegenerative Disease (Doctoral dissertation, University of Akron).
牛曼曼, 韩颖, 秦炯, æœå†›ä¿, 金红芳, 赵阳, å¼ é™, æŽæ²èŠ®. FMR1 åŸºå› å‰çªå˜çš„临床表现和分å机制. ä¸åŽå®žç”¨å„¿ç§‘临床æ‚å¿—. 2016 Jan 11(2016 å¹´ 20):1588-90.
Salcedo-Arellano MJ, Hagerman RJ, MartÃnez-Cerdeño V. SÃndrome de temblor y ataxia asociado al X frágil: presentación clÃnica, patologÃa y tratamiento. revista de NeurologÃa. 2019;199.
Srilatha B. A Review on Genetic Disorders and Syndromes. Biochem Mol Biol Lett. 2017;3(2):118.
El-Deeb M, Adams P, Schneider A, Salcedo-Arellano MJ, Tassone F, Hagerman R. Research Open. Journal of Molecular Genetics. 2018;1:1-4.
G Tan MM, S Dy JB, Salcedo-Arellano MJ, Tassone F, Hagerman RJ. Fragile X-associated neuropsychiatric disorders: a case report. Future Neurology. 2019:14.
Bonapace G, Gullace R, Concolino D, Iannello G, Procopio R, Gagliardi M, et al. Intracellular FMRpolyG-Hsp70 complex in fibroblast cells from a patient affected by fragile X tremor ataxia syndrome. Heliyon. 2019;5.
Akash R, Jasdeep S, Salcedo-Arellano M, Wilmar S, Xianlai D, Hagerman R. Fragile X syndrome and fragile X-associated disorders. F1000Research. 2017;6.
Wheeler AC, Miller S, Wylie A, Edwards A. Mindfulness and Acceptance as Potential Protective Factors for Mothers of Children With Fragile X Syndrome. Frontiers in public health. 2018;6:316.
Famula JL, McKenzie F, McLennan YA, Grigsby J, Tassone F, Hessl D, Rivera SM, Martinez-Cerdeno V, Hagerman RJ. Presence of middle cerebellar peduncle sign in FMR1 premutation carriers without tremor and ataxia. Frontiers in neurology. 2018;9.
El-Deeb M, Adams P, Schneider A, Salcedo-Arellano MJ, Tassone F, Hagerman R. Fentanyl Overdose in a female with the FMR1 premutation and FXTAS. Journal of molecular genetics (Isleworth, London, England). 2018;1.
Ligsay A, El-Deeb M, Salcedo-Arellano MJ, Schloemerkemper N, Grayson JS, Hagerman R. General anesthetic use in fragile X Spectrum disorders. Journal of neurosurgical anesthesiology. 2019;31:285-90.
Ligsay A, El-Deeb M, Salcedo-Arellano MJ, Schloemerkemper N, Grayson JS, Hagerman R. General anesthetic use in fragile X Spectrum disorders. Journal of neurosurgical anesthesiology. 2019;31:285-90.